Suita, Japan

Kyoichi Shimomura

This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyoichi Shimomura. Retrieved from https://idiyas.com/inventor/kyoichi-shimomura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1993-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kyoichi Shimomura: Innovator in Therapeutic Compounds

Introduction

Kyoichi Shimomura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 3 patents to his name, Shimomura's work has had a meaningful impact on medical treatments.

Latest Patents

Among his latest patents, Shimomura has developed vascular-permeability suppressants. These suppressants include an oxaspirooctane derivative of a specific general formula. Additionally, he has worked on thiazole derivatives, which are claimed to be useful as therapeutic agents for treating conditions such as rheumatism, nephritis, and thrombocytopenia.

Career Highlights

Kyoichi Shimomura is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to the creation of compounds that address critical health issues.

Collaborations

Throughout his career, Shimomura has collaborated with esteemed colleagues, including Masaaki Matsuo and Takashi Ogino. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research.

Conclusion

Kyoichi Shimomura's contributions to the field of pharmaceuticals exemplify the importance of innovation in medical science. His patents and collaborative efforts continue to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…